Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Histrelin Subdermal Implant in Children With Central Precocious Puberty
NCT00779103Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Sep 2004
- Primary completion
- Aug 2011
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of histrelin in central precocious puberty (CPP), sponsored by Endo International plc. Started Sep 2004; status: completed.
02
Drugs
histrelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on NCT00779103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779103.